Location

London

Employment Type

Full time

Location Type

On-site

Department

Office of the CEO

About Delfa

Billions of people still suffer from every‑day diseases.

One key reason? Clinical trials are broken.

Despite $120 billion spent each year, most trials are delayed due to bottlenecks like patient recruitment.

Delfa is fixing this with autonomous AI agents. We're building AI agents to automate clinical trials.

In less than a year from launch we've already:

• Deployed onto 300+ trials across multiple conditions
• Reached seven figures in ARR, growing 22% MoM
• Raised an oversubscribed $3.8m seed from tier‑one AI investors

Overview

Delfa is at a critical inflection: we have a proven offering which is on track to support the recruitment of thousands of participants into trials in 2026, while s...